However, one study found that a BMP9(-/-) transgenic model and a BMP9 inhibitor reduced right ventricular hypertrophy and distal muscularization of pulmonary arteries and reversed the hemodynamic parameters of hypoxic-PH mice [18]. The gene discussed is GDF2; the disease is Right ventricular hypertrophy.